Home/Filings/4/0001415889-25-023589
4//SEC Filing

Allan Jonathan 4

Accession 0001415889-25-023589

CIK 0001623526other

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 5:50 PM ET

Size

16.1 KB

Accession

0001415889-25-023589

Insider Transaction Report

Form 4
Period: 2025-08-29
Allan Jonathan
GENERAL COUNSEL & CORP SEC
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-08-2985024,951 total
    Exercise: $7.07Exp: 2032-12-06Common Stock (850 underlying)
  • Sale

    Common Stock

    2025-08-29$20.00/sh850$17,00023,948 total
  • Exercise/Conversion

    Common Stock

    2025-09-02$7.07/sh+9,150$64,69133,098 total
  • Sale

    Common Stock

    2025-09-02$20.14/sh14,922$300,49218,176 total
  • Exercise/Conversion

    Common Stock

    2025-08-29$7.07/sh+850$6,01024,798 total
  • Sale

    Common Stock

    2025-09-03$20.07/sh6,345$127,31711,831 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-09-029,15015,801 total
    Exercise: $7.07Exp: 2032-12-06Common Stock (9,150 underlying)
Footnotes (4)
  • [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.20, inclusive.
  • [F4]The option vested or vests as to 1/48th of the total award on January 7, 2023, with 1/48th of the total award vesting monthly thereafter, subject to the reporting person's continued service to the issuer through each vesting date.

Issuer

Stoke Therapeutics, Inc.

CIK 0001623526

Entity typeother

Related Parties

1
  • filerCIK 0001966716

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 5:50 PM ET
Size
16.1 KB